Serum potassium response to intravenous potassium chloride in severely hypokalemic patients from Ethiopia: A case series

Zablon Mesfin Anbessie
a:1:{s:5:"en_US";s:26:"Bethzatha general hospital";}
Dawit Kebede Huluka
Tikur Anbessa Hospital
Seifemichael Getachew Abebe
St. Paul Millennium Medical college
Share:
  • Articles
  • Submited: March 28, 2022
  • Published: October 1, 2022

Abstract

Introduction : One out of five admitted patients has hypokalemia, among which a similar number has severe hypokalemia, a life-threatening condition. The therapy and response of severe hypokalemia is mainly based on findings from other countries and in Ethiopia patients may have lower than recommended potassium replacement requirements, and as there have been no publications, this series was conducted to guide the clinical management of severely hypokalemic patients.

Methods: A nine-month prospective case series in Bethzatha general hospital ICU in Ethiopia were reviewed.

Case presentation-Six patients with a median age of 45 years were included. The range  of admission serum potassium level was (1 to 1.8) meq/l. An average  of 383 meqs of intravenous potassium chloride was infused to raise the serum potassium level by 2.57 meq/l. To raise the serum potassium level by 0.27meq/l an average of 39.4meq of potassium chloride was needed.

Conclusion: There was more than a half dose reduction in the potassium chloride infusion required to raise the serum potassium to the same target in the literature.

Downloads

Download data is not yet available.

References

  1. Ora Paltiel, MD, MSc; Edouard Salakhov, MD, MPH; Ilana Ronen, MPH; David Berg, BSc; Abraham Israeli, MD, MPH Ms. Management of Severe Hypokalemia in Hospitalized Patients. Arches Intern Med. 2001;161.
  2. Eliacik E, Yildirim T, Sahin U, Kizilarslanoglu C, Tapan U, Aybal-Kutlugun A, et al. Potassium abnormalities in current clinical practice: Frequency, causes, severity and management. Med Princ Pract. 2015;24(3):271–5.
  3. Kardalas E, Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G. Hypokalemia : a clinical update. 2018;(2):135–46.
  4. Kruse JA, Carlson RW. Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions. Arch Intern Med. 1990;150(3):613–7.
  5. Emmett M. Evaluation of the safety and efficacy of the central venous administration of potassium chloride including the measurement of intracardiac potassium concentrations. Baylor Univ Med Cent Proc [Internet]. 2020;33(1):24–7. Available from: https://doi.org/10.1080/08998280.2019.1678339
  6. Abramson E, Arky R. Diabetic Acidosis with Initial Hypokalemia: Therapeutic Implications. JAMA J Am Med Assoc. 1966;196(5):401–3.
  7. Johnston CT, Maish GO, Minard G, Croce MA, Dickerson RN. Evaluation of an Intravenous Potassium Dosing Algorithm for Hypokalemic Critically Ill Patients. J Parenter Enter Nutr. 2017;41(5):796–804.
  8. Lim S. Approach to hypokalemia. Acta Med Indones. 2007;39(1):56–64.
  9. Potassium / pH Correction Equation Page :: MediCalculator ::: ScyMed ::: [Internet]. [cited 2021 Oct 22]. Available from: http://www.scymed.com/en/smnxps/pshfp089.htm
  10. Alkaabi JM, Mushtaq A, Al-Maskari FN, Moussa NA, Gariballa S. Hypokalemic periodic paralysis: A case series, review of the literature and update of management. Eur J Emerg Med. 2010;17(1):45–7.
How to Cite
Mesfin, Z., Huluka, D., & Abebe, S. (2022). Serum potassium response to intravenous potassium chloride in severely hypokalemic patients from Ethiopia: A case series. Ethiopian Medical Journal, 60(4). Retrieved from https://emjema.org/index.php/EMJ/article/view/2126

Send mail to Author


Send Cancel